Hubert Kolb
#175,519
Most Influential Person Now
Researcher
Hubert Kolb's AcademicInfluence.com Rankings
Hubert Kolbcomputer-science Degrees
Computer Science
#10867
World Rank
#11455
Historical Rank
Computational Linguistics
#2739
World Rank
#2769
Historical Rank
Machine Learning
#4954
World Rank
#5012
Historical Rank
Artificial Intelligence
#5334
World Rank
#5406
Historical Rank
Download Badge
Computer Science
Hubert Kolb's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Hubert Kolb Influential?
(Suggest an Edit or Addition)Hubert Kolb's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) (815)
- C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. (2004) (462)
- An immune origin of type 2 diabetes? (2005) (414)
- C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. (2003) (357)
- Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes (2017) (355)
- Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. (2010) (335)
- Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? (1998) (301)
- The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation (2010) (291)
- Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study (2006) (291)
- Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors (2002) (278)
- Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes (2008) (245)
- Development of type 1 diabetes despite severe hereditary B-cell deficiency. (2001) (243)
- Sex differences in the relation of body composition to markers of inflammation. (2006) (237)
- Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. (2005) (224)
- Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype (2013) (203)
- The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. (1998) (195)
- Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers (2007) (188)
- Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). (2005) (179)
- Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation (1993) (179)
- Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. (2002) (173)
- Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. (1992) (168)
- Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7. Diabetes Care 2013;36:908–913 (2014) (167)
- Intake of Lactobacillus reuteri Improves Incretin and Insulin Secretion in Glucose-Tolerant Humans: A Proof of Concept (2015) (165)
- Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984–2002 (2006) (160)
- Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study (2009) (159)
- Increased Concentrations of C-Reactive Protein and IL-6 but not IL-18 Are Independently Associated With Incident Coronary Events in Middle-Aged Men and Women: Results From the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002 (2006) (158)
- Production and release of macrophage migration inhibitory factor from human adipocytes. (2005) (154)
- The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. (2005) (147)
- Systemic Bias of Cytokine Production Toward Cell-Mediated Immune Regulation in IDDM and Toward Humoral Immunity in Graves' Disease (1997) (140)
- Development of type 1 diabetes despite severe hereditary B lymphocyte deficiency: No pathogenic role of B lymphocytes (2000) (135)
- Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264)) (2004) (134)
- Chemokines and Incident Coronary Heart Disease: Results From the MONICA/KORA Augsburg Case-Cohort Study, 1984–2002 (2006) (127)
- Elevated Levels of Circulating Adhesion Molecules in IDDM Patients and in Subjects at Risk for IDDM (1992) (125)
- Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population (2005) (123)
- Diabetes classification: grey zones, sound and smoke: Action LADA 1 (2008) (122)
- Differential Expression of Chemokines, Risk of Stable Coronary Heart Disease, and Correlation with Established Cardiovascular Risk Markers (2006) (121)
- Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes (2006) (113)
- Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. (2004) (109)
- Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). (2006) (103)
- Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus (1994) (100)
- Nicotinamide in type 1 diabetes. Mechanism of action revisited. (1999) (100)
- Inflammation and type 2 diabetes: results from KORA Augsburg. (2005) (97)
- Meta-Analysis of Nicotinamide Treatment in Patients With Recent-Onset IDDM (1996) (95)
- Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4 (2011) (92)
- Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes. (2002) (87)
- Transfer of diabetes type 1 by bone-marrow transplantation (1998) (82)
- An association of autoantibody status and serum cytokine levels in type 1 diabetes. (2003) (80)
- Evidence of IgG Autoantibodies Against Human Proinsulin in Patients With IDDM Before Insulin Treatment (1988) (80)
- A multi-centre, blinded international trial of the effect of A1 and A2 β-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes (2002) (78)
- Insulin: too much of a good thing is bad (2020) (77)
- Increasing incidence of IDDM a consequence of improved hygiene? (1994) (77)
- Circulating forms of intercellular adhesion molecule (ICAM)-1 in mice lacking membranous ICAM-1. (2000) (76)
- The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. (2003) (75)
- HLA‐associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent‐onset insulin‐dependent diabetes mellitus (1996) (72)
- Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus (2006) (72)
- Benign versus destructive insulitis. (1997) (69)
- Resistance to type 2 diabetes mellitus: a matter of hormesis? (2012) (68)
- Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats (1998) (64)
- Cow's milk and type I diabetes: the gut immune system deserves attention. (1999) (63)
- Cytokine secretion patterns in twins discordant for Type I diabetes (1999) (60)
- Serum IFN‐γ and IL‐10 levels are associated with disease progression in non‐obese diabetic mice (2002) (59)
- Autoimmune versus inflammatory type I diabetes: a controversy? (1995) (58)
- Cytokine gene expression in the BB rat pancreas: natural course and impact of bacterial vaccines (1996) (57)
- A wheat-based, diabetes-promoting diet induces a Th1-type cytokine bias in the gut of NOD mice. (2003) (57)
- Proinflammatory Cytokines, Adiponectin, and Increased Risk of Primary Cardiovascular Events in Diabetic Patients With or Without Renal Dysfunction (2013) (57)
- Milk and Type I Diabetes: Examining the evidence and broadening the focus (1996) (54)
- Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes. (2008) (54)
- Cow’s milk and immune-mediated diabetes (2000) (53)
- Inflammation in Metabolic Syndrome and Type 2 Diabetes (2006) (50)
- Constitutive and regulated expression and secretion of interferon-γ-inducible protein 10 (IP-10/CXCL10) in human adipocytes (2007) (50)
- Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission (2007) (50)
- Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice. (2001) (48)
- Ketone bodies: from enemy to friend and guardian angel (2021) (46)
- Hypoadiponectinemia and Proinflammatory State: Two Sides of the Same Coin? (2006) (45)
- Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism--the Finnish Diabetes Prevention Study. (2011) (45)
- Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women (2005) (45)
- Change in patients’ body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrolective cohort study (2003) (44)
- Impact of dietary fat on Th1/Th2 cytokine gene expression in the pancreas and gut of diabetes-prone BB rats. (1998) (44)
- Insulin translates unfavourable lifestyle into obesity (2018) (44)
- Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4). (2007) (43)
- The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression (2007) (43)
- Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes (1998) (42)
- Is Self-Monitoring of Blood Glucose Appropriate for All Type 2 Diabetic Patients? The Fremantle Diabetes Study (2007) (40)
- Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: Action LADA 5 (2012) (40)
- Association of T-cell reactivity with beta-cell function in recent onset type 1 diabetes patients. (2010) (38)
- Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant (1997) (38)
- Autoantibodies to the islet antigen ICA 69 occur in IDDM and in rheumatoid arthritis (1995) (37)
- Follow-up of cyclosporin A treatment in Type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects (1991) (36)
- The Fourth International Workshop on the Standardisation of Insulin Autoantibody Measurement (2004) (36)
- Soluble ICAM-1 reduces leukocyte adhesion to vascular endothelium in ischemia-reperfusion injury in mice. (1998) (36)
- Health Effects of Coffee: Mechanism Unraveled? (2020) (36)
- Immunotherapy for Type 1 Diabetes: Why Do Current Protocols Not Halt the Underlying Disease Process? (2017) (36)
- C-Reactive Protein as a Predictor for Incident Diabetes Mellitus Among Middle-aged Men (2003) (34)
- Expression and secretion of RANTES (CCL5) in human adipocytes in response to immunological stimuli and hypoxia. (2009) (34)
- Soluble CD44 splice variants in metastasizing human breast cancer (1997) (33)
- Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults (1984) (32)
- Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). (2006) (32)
- Serum adipokines as biomarkers of beta‐cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin (2013) (32)
- Linear Loss of Insulin Secretory Capacity During the Last Six Months Preceding IDDM: No effect of antiedematous therapy with ketotifen (1994) (31)
- Proinsulin autoantibodies are more closely associated with Type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies (1991) (31)
- Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11 (2016) (31)
- The diabetes epidemic in the elderly population in Western Europe: data from population-based studies. (2005) (30)
- On what evidence-base do we recommend self-monitoring of blood glucose? (2010) (30)
- Cardiometabolic effects of two coffee blends differing in content for major constituents in overweight adults: a randomized controlled trial (2015) (29)
- Association of interferon‐γ and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes (2006) (28)
- Interleukin-6 in the prediction of primary cardiovascular events in diabetes patients: results from the ESTHER study. (2011) (28)
- Self-monitoring of blood glucose in type 2 diabetes: a new look at published trials (2008) (28)
- Genetics of type 2 diabetes: impact of interleukin-6 gene variants. (2005) (27)
- Prospective analysis of islet cell antibodies in children with Type 1 (insulin-dependent) diabetes (1988) (26)
- Does partial preservation of residual beta-cell function justify immune intervention in recent onset Type I diabetes? (2001) (25)
- Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial (2011) (25)
- Alternative Activation of Macrophage by IL-10 (2000) (24)
- Decreased expression of adhesion molecules on monocytes in recent onset IDDM. (1991) (23)
- Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial) (2012) (23)
- Intervention in autoimmune diabetes by targeting the gut immune system. (1997) (20)
- Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: action LADA 6. (2012) (20)
- IL-10 induces gene expression in macrophages: partial overlap with IL-5 but not with IL-4 induced genes. (2003) (20)
- Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes. (2006) (19)
- Insulin therapy of prediabetes suppresses TH1 associated gene expression in BB rat pancreas. (1997) (19)
- Self-monitoring of blood glucose in type 2 diabetes: an inter-country comparison. (2008) (19)
- Exogenous nitric oxide modulates cytokine production in human leukocytes. (1999) (18)
- Antibodies to Proinsulin and Insulin as Predictive Markers of Type 1 Diabetes (1990) (18)
- The rs1800629 polymorphism in the TNF gene interacts with physical activity on the changes in C-reactive protein levels in the Finnish Diabetes Prevention Study. (2010) (18)
- Nicotinamide and prevention of diabetes (1992) (18)
- Milk and type I diabetes. (1996) (17)
- Regeneration of beta-cells in response to islet inflammation. (2009) (17)
- Analysis of T-lymphocyte subpopulations in juvenile-onset diabetics. (1980) (16)
- Coffee and Lower Risk of Type 2 Diabetes: Arguments for a Causal Relationship (2021) (16)
- Towards a World Health Organisation (WHO) approved standard sample for islet cell antibodies, GAD65 and IA-2 autoantibodies (1999) (16)
- Evaluation of diagnostic relevance of mRNA levels in peripheral blood: predictive value for mortality in hemodialysis patients. (2004) (16)
- Association of humoral immunity to human Hsp60 with the IL-6 gene polymorphism C-174G in patients with type 2 diabetes and controls. (2005) (14)
- Interrelations between Diabetes Therapy, Self-Monitoring of Blood Glucose, Blood Glucose and Non-fatal or Fatal Endpoints in Patients with Type 2 Diabetes (2007) (14)
- Role of macrophages and cytokines in B-cell death (1996) (14)
- The Fourth International Workshop on the Standardisation of Insulin Autoantibody Workshop. (1990) (14)
- Soluble ICAM-1 reduces leukocyte adhesion to vascular endothelium in ischemia-reperfusion injury in mice. (1998) (14)
- Myocardial infarction and stroke in early years after diagnosis of type 2 diabetes: risk factors and relation to self-monitoring of blood glucose. (2009) (14)
- The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial) (2013) (12)
- Interleukin-10 is a predominant cytokine in atopic dermatitis. (1996) (12)
- Proinsulin autoantibodies: association with type I diabetes but not with islet cell antibodies, insulin autoantibodies or HLA-DR type. (1990) (11)
- ISLET CELL AUTOANTIBODIES: WHICH METHOD? (1983) (11)
- Non‐specific viral infections as possible synchronising events of the manifestation of Type 1 diabetes (2000) (11)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- A physiological role for circulating adhesion molecules? (1994) (10)
- Altered Disease Course after Initiation of Self-Monitoring of Blood Glucose in Noninsulin-Treated Type 2 Diabetes (ROSSO 3) (2007) (9)
- Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes (2013) (9)
- Immunotherapy in type 1 diabetes: present status. (1989) (9)
- Type 2 Diabetes Phenotype and Progression is Significantly Different if Diagnosed before versus after 65 Years of Age (2008) (8)
- [The Da Vinci Medical-mental motivation program for supporting lifestyle changes in patients with type 2 diabetes]. (2012) (8)
- Circulating levels of interleukin-18 independent of body fat and fat-free mass: results from the MONICA/KORA study. (2006) (7)
- Insulitis and islet-cell antibody formation in rats with experimentally reduced beta-cell mass (1995) (7)
- CRITERIA FOR IMMUNE TRIALS IN TYPE I DIABETES (1989) (6)
- Oral DNA vaccination with a plasmid encoding soluble ICAM-1 modulates cytokine expression profiles in nonobese diabetic mice (2002) (6)
- Cows' milk and insulin-dependent diabetes mellitus (1996) (6)
- Immune intervention in type I diabetes mellitus--current clinical and experimental approaches. (2009) (6)
- Inflammatory islet damage in patients bearing HLA-DR 3 and/or DR 4 haplotypes does not lead to islet autoimmunity (1994) (6)
- Interleukin-10 Is a Predominant Cytokine in Atopic Dermatitis (1996) (6)
- Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus (1989) (5)
- IMMUNOSUPPRESSIVE DRUGS IN DIABETES (1986) (5)
- A1 beta-casein milk and Type 1 diabetes: causal relationship probed in animal models. (2003) (5)
- Combined activation of innate and T cell immunity for recognizing immunomodulatory properties of therapeutic agents (2004) (5)
- Are Type 2 Diabetes Patients Who Self-Monitor Blood Glucose Special? The Role of Confounders in the Observational ROSSO Study (2009) (5)
- Sa.53. Chemokines and Risk of Myocardial Infarction: Results from the Monica/Kora Augsburg Study, 1984–2002 (2006) (4)
- Type I diabetes - an autoimmune disease? (1982) (4)
- Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes (2021) (4)
- Free radicals in the pathogenesis of diabetes and its complications (1995) (4)
- Dietary intervention for diabetes prevention in the neonate. (1998) (4)
- The Epidemiological Boehringer Ingelheim Employee Study (Part 3): Association of Elevated Fasting Insulin Levels but Not HOMA-IR With Increased Intima Media Thickness and Arteriosclerosis in Middle-Aged Persons (2021) (3)
- Type I Diabetes Mellitus: Rationale for Immune Intervention (1985) (3)
- INSULIN AUTOANTIBODIES—WHICH METHOD? (1989) (3)
- [Accidental transmission of type-1 diabetes mellitus with HLA-identical bone marrow]. (1993) (3)
- Association of interferon-gamma and interleukin 10 genotypes and serum levels with clinical remission in type 1 diabetes. (2006) (3)
- An immune origin of type 2 diabetes? (2005) (3)
- Comment on: Davidson MB (2007) The dilemma of self-monitoring of blood glucose. Diabetologia 50:497–499 (2007) (3)
- Helicobacter pylori seropositive subjects do not show a pronounced systemic inflammatory response even in the presence of the interleukin-1 receptor antagonist gene polymorphism (2004) (2)
- Immunological aspects of Type 1 (insulin-dependent) diabetes: Pathogenesis and therapy (1983) (2)
- Reply to comment on: Martin S, Schneider B, Heinemann L et al (2006) Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 49:271–278 (2006) (2)
- What do you see as the main priorities, Opportunities, and Challenges in Caffeine Research in the Next Five Years? (2011) (2)
- Effect of combined oral proteases and flavonoid treatment in subjects at risk of Type 1 diabetes (2009) (2)
- Antibodies to thymic hormone and HLA-DQ in type I diabetes (1990) (1)
- DETECTION OF ANTIHUMAN HSP60 ANTIBODY IN PATIENTS WITH TYPE I DIABETES (2003) (1)
- Humoral immune markers in early type 1 (insulin-dependent) diabetes: correlation between islet-cell antibodies and the incidence of insulin antibodies (1989) (1)
- Identification of pancreatic exocrinopathy in non-obese diabetic mice by gene subtraction analysis. (2004) (1)
- Endocrine and metabolic effects of dietary intake of probiotics in glucose tolerant humans (2013) (1)
- NOVEL GLYCOSAMINOGLYCAN IN SERA OF DIABETICS (1981) (1)
- The DREAM trial (2006) (1)
- S21.4: Gender differences in the relation of body composition parameters to markers of inflammation ‐ Results from the KORA Augsburg Survey 2000 (2004) (1)
- Rate of insulin degradation in different organs of diabetic rodents. Abstr. (1975) (1)
- Self-monitoring of blood glucose in type 2 diabetes: Steps toward consensus [2] (2007) (0)
- Eighth annual meeting of the European Association for the Study of Diabetes (1973) (0)
- Minutes of the 38th General Assembly of the European Association for the Study of Diabetes (2003) (0)
- Erratum to: Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4 (2011) (0)
- Impact of a Low-Insulin-Stimulating Bread on Weight Development—A Real Life Randomised Controlled Trial (2023) (0)
- Su.28. Association of Immune Mediators At Diagnosis of Type 1 Diabetes Mellitus with Later Clinical Remission (2006) (0)
- Subject Index Vol. 67, 1999 (2000) (0)
- Obese visceral fat tissue inflammation: from protective to detrimental? (2022) (0)
- Decreased secretion of GLP-1 and GLP-2 after oral glucose in obese versus lean healthy human subjects (2014) (0)
- Subject Index Vol. 67, 1999 (2000) (0)
- [Non-pharmacological diabetes therapy]. (2008) (0)
- Chapter 5 Association of Interferon-γ and Interleukin 10 Genotypes and Serum Levels with Partial Clinical Remission in Type 1 Diabetes (2011) (0)
- Abstract 4065: Chemokines and Risk of Myocardial Infarction: Results from the MONICA/KORA Augsburg Study, 1984 2002 (2006) (0)
- [Pilot study of controlled retrospective analysis (retrolective study design) of care for type 2 diabetics since 1990]. (2003) (0)
- Oral communications (2006) (0)
- The Effect of Atorvastatin on Beta-Cell Function (2010) (0)
- [Early diagnosis of type-1 diabetes. Limits, possibilities and outlook]. (1989) (0)
- Pathophysiology of type 1 diabetes mellitus. (2009) (0)
- On the aetiopathogenesis of type 1 diabetes: key roles for innate immunity and dietary antigens? (2009) (0)
- [Analysis of the quality of health care for patients with type 2 diabetes enrolled in statutory or private health plans]. (2008) (0)
- Expression and regulation of interferon-gamma inducible protein 10 (IP-10/CXCL10) in human adipocytes (2005) (0)
- Association of chemokine levels with C-peptide, HbA1c and proinsulin in patients with newly diagnosed diabetes mellitus type 1. Results from the Hvidøre study group (2006) (0)
- [Early detection of type I diabetes]. (1990) (0)
- Linear Loss of Insulin Secretory Capacity During the Last Six Months Preceding IPPM (1994) (0)
- Nitric Oxide as an Inflammatory Mediator in Insulin-Dependent Diabetes Mellitus (1994) (0)
- P2.47: Chronic infection with H pylori and systemic inflammatory response under consideration of the interleukin-1 receptor antagonist gene polymorphism in healthy adults (2004) (0)
- 1–14 Prélude: Macrophages in Inflammation / 15–35 Macrophages in Anti-Inflammation: Molecular Mechanisms / 36–46 Macrophages in Anti-Inflammation: Apoptosis / 47–56 Macrophages in Anti-Inflammation: Induction of Tolerance (2000) (0)
- ’ s response to reviews Title : Insulin translates unfavourable lifestyle into obesity (2018) (0)
- Autoimmune phenomena in type I diabetes mellitus (1986) (0)
- [Cyclosporin A as a diabetogenic cofactor]. (1986) (0)
- 1–14 Prélude: Macrophages in Inflammation / 15–35 Macrophages in Anti-Inflammation: Molecular Mechanisms / 36–46 Macrophages in Anti-Inflammation: Apoptosis / 47–56 Macrophages in Anti-Inflammation: Induction of Tolerance (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hubert Kolb?
Hubert Kolb is affiliated with the following schools:
